Table 3.

Relative expression of our candidate genes in different molecular subtypes of breast cancer and healthy breast tissue in GSE65194 and GSE45827.

Symbol	Basal-like		HER2-enriched		Luminal A		Luminal B
	logFC	adj.P.Val	logFC	adj.P.Val	logFC	adj.P.Val	logFC	adj.P.Val
MAD2L1	4.4	3.02E−61	3.57	6.58E−44	1.709	3.53E−13	3.297	4.45E−37
CCNA2	3.91	9.31E−50	2.78	1.50E−28	0.644	0.00823	1.986	1.09E−15
RAD51-AS1	− 1.6	1.47E−33	− 1.6	1.57E−30	− 0.9	6.18E−12	− 1.27	5.54E−21
LINC01089	− 1	2.44E−18	− 0.8	6.34E−11	− 0.32	0.00964	− 0.71	5.79E−09
EIF3J-DT	− 0.9	1.02E−13	− 0.8	1.66E−10	− 0.04	0.77445	− 0.46	0.00031
LINC02256	− 0.9	1.13E−21	− 0.9	3.56E−22	− 0.44	3.20E−06	− 0.57	1.22E−09
TNFRSF14-AS1	− 0.8	8.62E−26	− 0.8	6.44E−25	− 0.34	6.84E−06	− 0.5	7.35E−11
CARMN	− 3.2	6.13E−22	− 3	4.42E−18	− 1.91	4.53E−08	− 2.41	5.23E−12
EPB41L4A-AS1	− 1.6	1.78E−20	− 1.3	2.99E−13	− 0.7	0.0002	− 1.24	3.19E−11
LINC01279	− 2.1	2.58E−08	− 0.9	0.022916	0.484	0.27445	− 0.66	0.10494
MEG3	− 2.8	7.98E−40	− 2.1	2.33E−25	− 1.55	5.77E−14	− 1.91	8.24E−20
FUT8-AS1	− 0.8	2.61E−31	− 0.8	7.15E−26	− 0.49	5.63E−11	− 0.55	1.80E−13
PRINS	− 1.2	4.18E−44	− 1.2	2.64E−38	− 0.92	4.31E−24	− 1.09	1.10E−31
NCK1-DT	1.58	1.22E−22	0.94	4.64E−09	0.625	0.00022	0.897	8.21E−08

logFC, log2 fold change; adj.P.Val, adjusted P value.